Born at 24 weeks: baby Jack’s story
The decision to start a family was an easy one for Darren and Dani. After six great years together, they knew they were ready for parenthood. “It was the best…… Read more
…with Crohn’s disease around the same time as me. She’s not really in full remission yet, but about the best that she’s been. It was really hard on my parents…… Read more
The decision to start a family was an easy one for Darren and Dani. After six great years together, they knew they were ready for parenthood. “It was the best…… Read more
…is to find treatments that can be translated into best practice healthcare. Since the pandemic began, Hudson Institute has been part of the global fight against severe COVID-19 inflammation. Our…… Read more
…don’t suffer as much and can be diagnosed earlier,” Kat says. Diseases we research Endometriosis | Learn more Contact us Hudson Institute communications t: + 61 3 8572 2697 e: communications@hudson.org.au…… Read more
…be mentored and interact with some of Australia’s best health and medical scientists,” A/Prof Atul Malhotra said. Contact us Hudson Institute communications t: + 61 3 8572 2761 e: communications@hudson.org.au…… Read more
…done,” Dr Änkö says. Learn more about Inflammation Read more stories like this in our 2021 Annual Report Contact us Hudson Institute communications t: + 61 3 8572 2761 e: communications@hudson.org.au…… Read more
…New Zealand and the United States. They are investigating many aspects of the role creatine may play in producing healthy mothers and babies. What is creatine? Creatine is a compound…… Read more
…on improving PA detection and patient outcomes.” MRFF preterm baby project Dr Courtney McDonald Dr Courtney McDonald works to give very preterm babies the best possible start in life and…… Read more
…to facilitate the commercialisation of her women’s health research. “Through the REDI fellowship, I will gain exposure to industry best practices, business development strategies and commercialisation frameworks specific to the…… Read more
…now being commercialised by ASX-bound Australian company Cleo Diagnostics Ltd. Cleo will advance the availability of its cancer diagnostics platform, which is designed to eventually address all ovarian cancer detection…… Read more